clinical trial · NCT06342310
RE104 Safety and Efficacy Study in Postpartum Depression
Postpartum DepressionRE104 for Injection
brief summary
The purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces depressive symptoms in participants with moderate-to-severe postpartum depression (PPD) as compared to active-placebo.
started
Jun 14, 2024
primary completion
May 22, 2025
completion
Jun 16, 2025
last updated
Jul 23, 2025
official title
A Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients With Postpartum Depression (PPD)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol